Daclatasvir Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 30 mg, 60 mg

Reference Brands: Daklinza® (US & EU)

Category: Hepatitis

Daclatasvir is available in Tablet and strengths such as 30 mg, 60 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Daclatasvir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Daclatasvir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Daclatasvir is a potent direct-acting antiviral (DAA) used in the treatment of chronic Hepatitis C virus (HCV) infection. It functions by selectively inhibiting the NS5A protein, a key factor in viral replication and assembly. Available as oral tablets in strengths of 30 mg and 60 mg, Daclatasvir is commonly used in combination with Sofosbuvir or other antivirals for broad genotype coverage. Manufactured under strict EU-GMP and USFDA standards, it is suitable for B2B supply, hospital tenders, and licensing. Comprehensive regulatory dossiers support fast market registration and global distribution.